EpiDerm

Histamine AND histamine antagonists). It is formed from histidine by the enzyme L-histidine decarboxylase. In the periphery, histamine is stored ia mast cells, basophils, cells of the gastric mucosa, and epidermal cells. In the CNS, histamine is released from nerve cells and acts as a neurotransmitter. The actions of histamine ate terrninated by methylation and subsequent oxidation via the enzymes histamine-/V-methyltransferase and monoamine oxidase. 

Whereas epidermal growth factor (EGF) enhances the radiosensitivity of human squamous ceU carcinoma cells in vitro (197), addition of EGF to hormone-deprived MCE-7 breast cancer cells prior to irradiation results ia iacreased radioresistance (198). An anti-EGE-receptor monoclonal antibody blocks the abiUty of EGE to enhance growth and radioresistance. Tumor cells, the growth of which is stimulated by EGE, appear to be protected those where growth is iohibited are sensitized (198). 

There are hundreds of topical steroid preparations that are available for the treatment of skin diseases. In addition to their aforementioned antiinflammatory effects, topical steroids also exert their effects by vasoconstriction of the capillaries in the superficial dermis and by reduction of cellular mitosis and cell proliferation especially in the basal cell layer of the skin. In addition to the aforementioned systemic side effects, topical steroids can have adverse local effects. Chronic treatment with topical corticosteroids may increase the risk of bacterial and fungal infections. A combination steroid and antibacterial agent can be used to combat this problem. Additional local side effects that can be caused by extended use of topical steroids are epidermal atrophy, acne, glaucoma and cataracts (thus the weakest concentrations should be used in and around the eyes), pigmentation problems, hypertrichosis, allergic contact dermatitis, perioral dermatitis, and granuloma gluteale infantum (251). 

Emulsion components enter the stratum corneum and other epidermal layers at different rates. Most of the water evaporates, and a residue of emulsifiers, Hpids, and other nonvolatile constituents remains on the skin. Some of these materials and other product ingredients may permeate the skin others remain on the surface. If the blend of nonvolatiles materially reduces the evaporative loss of water from the skin, known as the transepidermal water loss (TEWL), the film is identified as occlusive. AppHcation of a layer of petrolatum to normal skin can reduce the TEWL, which is normally about 4—8 g/(m h), by as much as 50 to 75% for several hours. The evaporated water is to a large extent trapped under the occlusive layer hydrating or moisturizing the dead cells of the stratum corneum. The flexibiHty of isolated stratum corneum is dependent on the presence of water dry stratum corneum is britde and difficult to stretch or bend. Thus, any increase in the water content of skin is beHeved to improve the skin quaHty. 

Air pollutants may enter plant systems by either a primary or a secondary pathway. The primary pathway is analogous to human inhalation. Figure 8-2 shows the cross section of a leaf. Both of the outer surfaces are covered by a layer of epidermal cells, which help in moisture retention. Between the epidermal layers are the mesophyll cells—the spongy and palisade parenchyma. The leaf has a vascular bundle which carries water, minerals, and carbohydrates throughout the plant. Two important features shown in Fig. 8-2 are the openings in the epidermal layers called stomates, which are controlled by guard cells which can open and close, and air spaces in the interior of the leaf. 

These three functions involve the movement of O2, CO2, and HjO through the epidermal layers of the leaf. The analogy to human inhalation is obvious. With the diffusion of gases into and out of the leaf, pollutant gases have a direct pathway to the cellular system of the leaf structure. Direct deposition of particulate matter also occurs on the outer surfaces of the leaves. 

Figure 2.19 Organization of polypeptide chains into domains. Small protein molecules like the epidermal growth factor, EGF, comprise only one domain. Others, like the serine proteinase chymotrypsin, are arranged in two domains that are required to form a functional unit (see Chapter 11). Many of the proteins that are involved in blood coagulation and fibrinolysis, such as urokinase, factor IX, and plasminogen, have long polypeptide chains that comprise different combinations of domains homologous to EGF and serine proteinases and, in addition, calcium-binding domains and Kringle domains.

Domains that are homologous to the epidermal growth factor, EGF, which is a small polypeptide chain of 53 amino acids. 

FIGURE 6.38 A sampling of proteins that consist of mosaics of individual protein modules. The modules shown include 7CG, a module containing 7-carboxyglutamate residues G, an epidermal growth-factor-like module K, the kringle domain, named for a Danish pastry ... 

These interactions involve adhesion proteins called selectins, which are found both on the rolling leukocytes and on the endothelial cells of the vascular walls. Selectins have a characteristic domain structure, consisting of an N-terminal extracellular lectin domain, a single epidermal growth factor (EGR) domain, a series of two to nine short consensus repeat (SCR) domains, a single transmembrane segment, and a short cytoplasmic domain. Lectin domains, first characterized in plants, bind carbohydrates... 

III. Tyr protein kinases A. Cytosolic tyrosine kinases src, fgr, abl, etc.) B. Receptor tyrosine kinases (RTKs) Plasma membrane receptors for hormones such as epidermal growth factor (EGF) or platelet-derived growth factor (PDGE) Raf (a protein kinase)... 

Investigation of cytotoxic antitumor activity of phthalocyanin conjugates with epidermal growth factor 98MI55. 

Oberhaut-. epidermic, epidermal. Ober-hMutchen, n. cuticle, -hefe, /. top yeast. 

The two isozymes are both homodimers, composed of approximately 600 amino acids and possess approximately 60% homology. The three-dimensional structures of COX-1 and COX-2 are very similar. Each one consists of three independent units an epidermal growth factor-like domain, a membrane-binding section and an enzymic domain. The catalytic sites and the residues immediately adjacent are identical but for two small but crucial variations that result in an increase in the volume of the COX-2-active site, enabling it to accept inhibitor-molecules larger than those that could be accommodated in the COX-1 molecule. 

The epidermal growth factor receptor 2 (HER-2) is a protein found on the surface of cells. Heterodimerization of HER-2 activates the enzyme tyrosine kinase, triggering reactions that cause the cells to grow and multiply. HER-2 is found at abnormally high levels on the surface of many types of cancer cells, which may divide excessively. Antibodies targeting HER-2 (e.g., trastuzumab) are used as antineoplastic agents. 

Epidermal Growth Factor Receptor Family Growth Factors... 

The regulation of NHE2 is multifactorial. Chronic exposure to nitric oxide and gamma-interferon decrease NHE2 activity, whereas metabolic acidosis and chronic stimulation with epidermal growth factor (EGF) increase activity. 

---